01 September 2022>: Clinical Research
High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
Iwona Homa-Mlak 1ACDEF* , Radosław Mlak 1ACDEF , Anna Brzozowska 2BDF , Marcin Mazurek 1CEF , Tomasz Powrózek 1CDF , Monika Prendecka-Wróbel 1CEF , Aneta Szudy-Szczyrek 2ADE , Piotr Dreher 3CEF , Katarzyna Kamińska 4F , Teresa Małecka-Massalska 1ACEF , Alicja Wójcik-Załuska 5CEGDOI: 10.12659/MSM.936857
Med Sci Monit 2022; 28:e936857
Table 3 The relationship between factors reflecting malnutrition status and irisin level in HNC patients.
Factor | Cases (n=50) | Irisin level median (95% CI) | p | |
---|---|---|---|---|
NRS-2002 | 34 (68%) | 1.18 (1.09–1.35) | 0.0004* | |
≥3 | 16 (32%) | 1.57 (1.36–2.12) | ||
SGA | A | 8 (16%) | 1.07 (0.70–1.29) | 0.0139* |
B and C | 42 (84%) | 1.38 (1.23–1.51) | ||
SGA | A and B | 32 (64%) | 1.23 (1.14–1.39) | 0.0630 |
C | 18 (36%) | 1.45 (1.20–1.74) | ||
BMI I (kg/m) | 5 (10%) | 2.53 (−) | 0.0585 | |
>18.5 | 45 (90%) | 1.33 (1.16–1.42) | ||
BMI VII (kg/m) | 12 (24%) | 1.31 (1.14–2.40) | 0.3880 | |
>18.5 | 38 (76%) | 1.33 (1.16–1.43) | ||
Total protein | Normal | 45 (90%) | 1.33 (1.18–1.45) | 0.9099 |
Abnormal (lowered) | 5 (10%) | 1.27 (−) | ||
Albumin | Normal | 12 (24%) | 1.28 (0.99–1.66) | 0.8380 |
Abnormal (lowered) | 38 (76%) | 1.33 (1.17–1.43) | ||
Transferrin | Norma | 41 (82%) | 1.33 (1.20–1.45) | 0.5034 |
Abnormal (lowered) | 9 (18%) | 1.19 (0.98–1.56) | ||
Parenteral nutrition | Yes | 8 (16%) | 1.56 (1.16–4.22) | 0.0416* |
No | 42 (84%) | 1.27 (1.14–1.40) | ||
Antibiotic | Yes | 14 (28%) | 1.31 (1.08–1.69) | 0.8628 |
No | 36 (72%) | 1.36 (1.17–1.44) | ||
* Statistically significant results. BMI – body mass index; NRS-2002 – Nutritional Risk Screening 2002; SGA – Subjective Global Assessment. |